Follicular thyroid carcinoma: response to chemotherapy.
A 69-year-old woman with far advanced inoperable follicular carcinoma of the thyroid became refractory to radioactive iodine therapy and to combination chemotherapy with adriamycin and cyclophosphamide. She then attained a good clinical response to chemotherapy with adriamycin, CCNU and methotrexate (ACMe); this lasted more than a year. The regimen of adriamycin, CCNU, and methotrexate deserves further study for patients with follicular thyroid carcinoma.